Helius Medical Technologies, Inc. Announces Partnership with Lovell Government Services to Expand Reach of PoNS Therapy
Portfolio Pulse from Benzinga Newsdesk
Helius Medical Technologies, Inc. (NASDAQ:HSDT) has announced a partnership with Lovell Government Services to make its PoNS device, a therapeutic neuromodulation approach for balance and gait deficits, available to federal healthcare systems. The PoNS device is indicated for short-term treatment of gait deficit in adults with mild-to-moderate symptoms from MS when used alongside physical therapy.
April 03, 2024 | 11:08 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Helius Medical Technologies, Inc. announces a partnership with Lovell Government Services to distribute its PoNS device to federal healthcare systems, potentially expanding its market reach.
The partnership with Lovell Government Services, a company with access to federal healthcare systems, could significantly expand the market reach of Helius Medical Technologies' PoNS device. This expansion into federal healthcare systems represents a substantial opportunity for increased adoption and sales of the PoNS device, potentially leading to positive impacts on the company's financial performance and stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100